384 related articles for article (PubMed ID: 26638918)
21. [Malignant pleural mesothelioma: The role of surgery].
Fournel L; Janet-Vendroux A; Canny-Hamelin E; Mansuet-Lupo A; Guinet C; Bobbio A; Damotte D; Alifano M
Rev Pneumol Clin; 2018 Oct; 74(5):351-358. PubMed ID: 30316650
[TBL] [Abstract][Full Text] [Related]
22. Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly.
Williams T; Duraid H; Watson S; Durkin A; Todd K; Kindler HL; Vigneswaran WT
Ann Thorac Surg; 2015 Nov; 100(5):1868-74. PubMed ID: 26319490
[TBL] [Abstract][Full Text] [Related]
23. Pleurectomy-decortication in malignant pleural mesothelioma: are different surgical techniques associated with different outcomes? Results from a multicentre study.
Marulli G; Breda C; Fontana P; Ratto GB; Leoncini G; Alloisio M; Infante M; Luzzi L; Paladini P; Oliaro A; Ruffini E; Benvenuti MR; Pariscenti G; Spaggiari L; Casiraghi M; Rusca M; Carbognani P; Ampollini L; Facciolo F; Leuzzi G; Mucilli F; Camplese P; Romanello P; Perissinotto E; Rea F
Eur J Cardiothorac Surg; 2017 Jul; 52(1):63-69. PubMed ID: 28419212
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma.
Hasegawa S; Yokoi K; Okada M; Tanaka F; Shimokawa M; Daimon T; Nakano T
J Thorac Cardiovasc Surg; 2022 Jun; 163(6):1940-1947.e5. PubMed ID: 34419248
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics, treatment and survival outcomes in malignant pleural mesothelioma: an institutional experience in Turkey.
Kucukoner M; Ali Kaplan M; Inal A; Urakci Z; Abakay O; Cetin Tanrikulu A; Abakay A; Selim Sen H; Turkcu G; Senyigit A; Buyukbayram H; Isikdogan A
J BUON; 2014; 19(1):164-70. PubMed ID: 24659659
[TBL] [Abstract][Full Text] [Related]
26. A feasibility study of induction pemetrexed plus cisplatin followed by pleurectomy/decortication aimed at macroscopic complete resection for malignant pleural mesothelioma.
Shimokawa M; Hasegawa S; Fukuoka K; Okada M; Yokoi K; Tanaka F; Yamanaka T; Daimon T; Nakano T
Jpn J Clin Oncol; 2013 May; 43(5):575-8. PubMed ID: 23509402
[TBL] [Abstract][Full Text] [Related]
27. Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma-A Prospective Report.
Bongiolatti S; Mazzoni F; Salimbene O; Caliman E; Ammatuna C; Comin CE; Antonuzzo L; Voltolini L
J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884251
[TBL] [Abstract][Full Text] [Related]
28. Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma.
Marulli G; Faccioli E; Bellini A; Mammana M; Rea F
Expert Rev Respir Med; 2017 Aug; 11(8):649-660. PubMed ID: 28580813
[TBL] [Abstract][Full Text] [Related]
29. Is less also better? A single-institution experience on treatment of early stage Malignant Pleural Mesothelioma.
Bertoglio P; Ambrogi MC; Chella A; Aprile V; Dini P; Korasidis S; Fanucchi O; Mussi A
Eur J Surg Oncol; 2017 Jul; 43(7):1365-1371. PubMed ID: 28274663
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma.
van Ruth S; van Tellingen O; Korse CM; Verwaal VJ; Zoetmulder FA
Anticancer Drugs; 2003 Jan; 14(1):57-65. PubMed ID: 12544259
[TBL] [Abstract][Full Text] [Related]
31. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation.
Sauter ER; Langer C; Coia LR; Goldberg M; Keller SM
J Surg Oncol; 1995 Oct; 60(2):100-5. PubMed ID: 7564374
[TBL] [Abstract][Full Text] [Related]
32. Current Treatment of Mesothelioma: Extrapleural Pneumonectomy Versus Pleurectomy/Decortication.
Wolf AS; Flores RM
Thorac Surg Clin; 2016 Aug; 26(3):359-75. PubMed ID: 27427530
[TBL] [Abstract][Full Text] [Related]
33. Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma.
Rusch VW
Chest; 1993 Apr; 103(4 Suppl):382S-384S. PubMed ID: 8462330
[TBL] [Abstract][Full Text] [Related]
34. Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma.
Klotz LV; Lindner M; Eichhorn ME; Grützner U; Koch I; Winter H; Kauke T; Duell T; Hatz RA
J Thorac Dis; 2019 May; 11(5):1963-1972. PubMed ID: 31285889
[TBL] [Abstract][Full Text] [Related]
35. A Phase II Trial of Nivolumab With Chemotherapy Followed by Maintenance Nivolumab in Patients With Pleural Mesothelioma After Surgery: The NICITA Study Protocol.
Shah R; Klotz LV; Chung I; Feißt M; Schneider MA; Riedel J; Bischoff H; Eichhorn ME; Thomas M
Clin Lung Cancer; 2021 Mar; 22(2):142-146. PubMed ID: 33158765
[TBL] [Abstract][Full Text] [Related]
36. Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma.
Hasegawa S
Gen Thorac Cardiovasc Surg; 2014 Sep; 62(9):516-21. PubMed ID: 24639000
[TBL] [Abstract][Full Text] [Related]
37. Extended pleurectomy decortication for malignant pleural mesothelioma in the elderly: the need for an inclusive yet selective approach.
Sharkey AJ; Bilancia R; Tenconi S; Nakas A; Waller DA
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):696-702. PubMed ID: 29049744
[TBL] [Abstract][Full Text] [Related]
38. Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience.
Ambrogi MC; Bertoglio P; Aprile V; Chella A; Korasidis S; Fontanini G; Fanucchi O; Lucchi M; Mussi A
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1857-1866.e2. PubMed ID: 29191688
[TBL] [Abstract][Full Text] [Related]
39. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
Sugarbaker DJ; Gill RR; Yeap BY; Wolf AS; DaSilva MC; Baldini EH; Bueno R; Richards WG
J Thorac Cardiovasc Surg; 2013 Apr; 145(4):955-963. PubMed ID: 23434448
[TBL] [Abstract][Full Text] [Related]
40. Perioperative anesthetic management of patients with malignant pleural mesothelioma undergoing cytoreductive surgery and intraoperative chemotherapy.
Gómez Tarradas JM; Pujol Fontrodona G; López-Baamonde M; Sánchez D; Jiménez MJ; Navarro-Ripoll R
Rev Esp Anestesiol Reanim (Engl Ed); 2020 Jan; 67(1):15-19. PubMed ID: 31353039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
